Palonosetron

Moderately emetogenic cancer chemotherapy- prevention of acute and delayed nausea and vomiting associated with initial and repeat courses

Highly emetogenic cancer chemotherapy- prevention of acute nausea and vomiting associated with initial and repeat courses

Prevention of postoperative nausea and vomiting (PONV) for up to 24 hours following surgery. Efficacy beyond 24 hours has not been demonstrated.

There are no products to list in this category.

Continue